Dot-immunobinding assay using indirect photoacoustic measurement

Area of Science:

• Biomedical Engineering
• Analytical Chemistry
• Hepatology

Background:

• Hepatitis B virus (HBV) infection remains a significant global health concern.
• Accurate and sensitive detection of hepatitis B surface antigen (HBsAg) is crucial for diagnosis and management.
• Conventional methods like dot-ELISA have limitations in sensitivity and quantitative accuracy.

Purpose of the Study:

• To develop and validate a sensitive quantitative photoacoustic method for HBsAg detection.
• To optimize the operational conditions for the indirect photoacoustic measurement of dot-immunobinding assays.
• To assess the method's performance compared to negative controls.

Main Methods:

• Dot-immunobinding assay utilizing a conventional dot-ELISA technique with 4-chloro-1-naphthol staining.
• Quantitative measurement of HBsAg spots using an indirect photoacoustic method.
• Application of a 2-mW helium-neon laser for excitation and detection via a piezoelectric transducer-based photoacoustic cell.

Main Results:

• Optimized operational conditions for the photoacoustic measurement.
• Achieved significant differentiation between positive and negative human serum samples.
• Demonstrated detection sensitivity down to 50 pg of HBsAg.

Conclusions:

• The proposed indirect photoacoustic method offers a sensitive and quantitative approach for HBsAg detection in dot-immunobinding assays.
• This technique enhances the diagnostic utility of dot-ELISA for hepatitis B.
• The optimized method shows promise for improved HBsAg screening and monitoring.